MedPage Today

'Practice-Changing' Data in Locally Advanced Cervical Cancer

Results from a pair of international phase III trials testing two distinct treatment strategies will usher in new standards of care for women with newly diagnosed, locally advanced cervical cancer, researchers reported here. "This is a celebration," said Bradley Monk, MD, — an associate professor of Obstetrics and Gynecology at the University of Arizona College of Medicine – Phoenix, who served as discussant for the pembrolizumab presentation. "We're challenging a treatment paradigm that has stood for more than 2 decades."

Topics

About the College

Founded in 2007, the University of Arizona College of Medicine – Phoenix inspires and trains exemplary physicians, scientists and leaders to optimize health and health care in Arizona and beyond. By cultivating collaborative research locally and globally, the college accelerates discovery in a number of critical areas — including cancer, stroke, traumatic brain injury and cardiovascular disease. Championed as a student-centric campus, the college has graduated more than 900 physicians, all of whom received exceptional training from nine clinical partners and more than 2,700 diverse faculty members. As the anchor to the Phoenix Bioscience Core, which is projected to have an economic impact of $3.1 billion by 2025, the college prides itself on engaging with the community, fostering education, inclusion, access and advocacy.